SYNERGIE CELL & GENE+ PATIENT NAVIGATION
Live / Registered — Registered (as of 07 Jan 2025)
What this means for you
Registered since 07 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98055807
- Registration number
- 7645615
- Mark type
- Stylized text
- Filed
- 23 Jun 2023
- Published for opposition
- 30 Jan 2024
- Registered
- 07 Jan 2025
- Attorney of record
- Patricia I. Reding
Goods and services
- Class 035 — Advertising and business services: Patient routing and care management, designed to lower the cost of cell and gene treatment in the nature of administering discount group purchasing programs, namely, facilitating and negotiating contracts with providers of cell and gene therapy to enable benefit plan participating health care payers to obtain discounts on the purchase of their goods or services
Owner
- Synergie Medication Collective, LLC, Wilmington, DE, US
- Synergie Medication Collective, LLC, Wilmington, DE, US
- Synergie Medication Collective, LLC, Wilmington, DE, US
Prosecution history
- 07 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Dec 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Dec 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Sept 2024 — USE AMENDMENT FILED
- 16 Nov 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Sept 2024 — TEAS STATEMENT OF USE RECEIVED
- 26 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jan 2024 — PUBLISHED FOR OPPOSITION
- 10 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE